» Articles » PMID: 33046554

Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation

Overview
Journal J Neurosci
Specialty Neurology
Date 2020 Oct 13
PMID 33046554
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The formation of memory for a novel experience is a critical cognitive capacity. The ability to form novel memories is sensitive to age-related pathologies and disease, to which prolonged metabolic stress is a major contributing factor. Presently, we describe a dopamine-dependent redox modulation pathway within the hippocampus of male mice that promotes memory consolidation. Namely, following novel information acquisition, quinone reductase 2 (QR2) is suppressed by miRNA-182 (miR-182) in the CA1 region of the hippocampus via dopamine D1 receptor (D1R) activation, a process largely facilitated by locus coeruleus activity. This pathway activation reduces ROS generated by QR2 enzymatic activity, a process that alters the intrinsic properties of CA1 interneurons 3 h following learning, in a form of oxidative eustress. Interestingly, novel experience decreases QR2 expression predominately in inhibitory interneurons. Additionally, we find that in aged animals this newly described QR2 pathway is chronically under activated, resulting in miR-182 underexpression and QR2 overexpression. This leads to accumulative oxidative stress, which can be seen in CA1 via increased levels of oxidized, inactivated potassium channel Kv2.1, which undergoes disulfide bridge oligomerization. This newly described interneuron-specific molecular pathway lies alongside the known mRNA translation-dependent processes necessary for long-term memory formation, entrained by dopamine in CA1. It is a process crucial for the distinguishing features of novel memory, and points to a promising new target for memory enhancement in aging and age-dependent diseases. One way in which evolution dictates which sensory information will stabilize as an internal representation, relies on information novelty. Dopamine is a central neuromodulator involved in this process in the mammalian hippocampus. Here, we describe for the first time a dopamine D1 receptor-dependent quinone reductase 2 pathway in interneurons. This is a targeted redox event necessary to delineate a novel experience to a robust long-term internal representation. Activation of this pathway alone can explain the effect novelty has on "flashbulb" memories, and it can become dysfunctional with age and diseases, such as Alzheimer's disease.

Citing Articles

Evolutionary analysis of Quinone Reductases 1 and 2 suggests that NQO2 evolved to function as a pseudoenzyme.

Islam F, Basilone N, Yoo V, Ball E, Shilton B Protein Sci. 2024; 33(12):e5234.

PMID: 39584664 PMC: 11586865. DOI: 10.1002/pro.5234.


Homeostatic Shrinkage of Dendritic Spines Requires Melatonin Type 3 Receptor Activation During Sleep.

Li S, Li X, Lu M, Chen Q, Yao D, Yu X Adv Sci (Weinh). 2024; 11(38):e2400253.

PMID: 39119847 PMC: 11481193. DOI: 10.1002/advs.202400253.


The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice.

Vallucci M, Boutin J, Janda E, Blandel F, Musgrove R, Di Monte D J Neural Transm (Vienna). 2023; 131(1):1-11.

PMID: 37851107 DOI: 10.1007/s00702-023-02709-3.


Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice.

Gould N, Scherer G, Carvalho S, Shurrush K, Kayyal H, Edry E J Clin Invest. 2023; 133(19).

PMID: 37561584 PMC: 10541198. DOI: 10.1172/JCI162120.


Learning and memory formation in zebrafish: Protein dynamics and molecular tools.

Reemst K, Shahin H, Shahar O Front Cell Dev Biol. 2023; 11:1120984.

PMID: 36968211 PMC: 10034119. DOI: 10.3389/fcell.2023.1120984.


References
1.
Janda E, Lascala A, Carresi C, Parafati M, Aprigliano S, Russo V . Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for neuroprotection. Autophagy. 2015; 11(7):1063-80. PMC: 4590600. DOI: 10.1080/15548627.2015.1058683. View

2.
Gould N, Elkobi A, Edry E, Daume J, Rosenblum K . Muscarinic-Dependent miR-182 and QR2 Expression Regulation in the Anterior Insula Enables Novel Taste Learning. eNeuro. 2020; 7(3). PMC: 7266141. DOI: 10.1523/ENEURO.0067-20.2020. View

3.
Kwapis J, Jarome T, Schiff J, Helmstetter F . Memory consolidation in both trace and delay fear conditioning is disrupted by intra-amygdala infusion of the protein synthesis inhibitor anisomycin. Learn Mem. 2011; 18(11):728-32. PMC: 3207254. DOI: 10.1101/lm.023945.111. View

4.
Rappaport A, Jacob E, Sharma V, Inberg S, Elkobi A, Ounallah-Saad H . Expression of Quinone Reductase-2 in the Cortex Is a Muscarinic Acetylcholine Receptor-Dependent Memory Consolidation Constraint. J Neurosci. 2015; 35(47):15568-81. PMC: 6705469. DOI: 10.1523/JNEUROSCI.1170-15.2015. View

5.
Gulledge A, Dasari S, Onoue K, Stephens E, Hasse J, Avesar D . A sodium-pump-mediated afterhyperpolarization in pyramidal neurons. J Neurosci. 2013; 33(32):13025-41. PMC: 3735883. DOI: 10.1523/JNEUROSCI.0220-13.2013. View